139 related articles for article (PubMed ID: 37730243)
1. Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa.
Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Suleman F
BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37730243
[TBL] [Abstract][Full Text] [Related]
2. Understanding the decision making process of selection of medicines in the private sector in South Africa - lessons for low-middle income countries.
Perumal-Pillay VA; Suleman F
J Pharm Policy Pract; 2020; 13():17. PubMed ID: 32477570
[TBL] [Abstract][Full Text] [Related]
3. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
4. Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.
Matlala M; Gous AGS; Meyer JC; Godman B
Front Pharmacol; 2020; 11():1267. PubMed ID: 32973508
[TBL] [Abstract][Full Text] [Related]
5. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
Mattila PO; Babar ZU; Suleman F
BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
[TBL] [Abstract][Full Text] [Related]
6. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
Tang B; Bodkyn C; Gupta S; Denburg A
JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
[TBL] [Abstract][Full Text] [Related]
7. Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa.
Magadzire BP; Ward K; Leng HMJ; Sanders D
S Afr Med J; 2017 Jun; 107(7):581-584. PubMed ID: 29025446
[TBL] [Abstract][Full Text] [Related]
8. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
[TBL] [Abstract][Full Text] [Related]
9. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
[TBL] [Abstract][Full Text] [Related]
10. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
Coghlan R; Stephens P; Mwale B; Siyanga M
Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
[TBL] [Abstract][Full Text] [Related]
11. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
12. Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries.
Mpanza NM; Godman B; Keele MG; Matlala M
BMC Public Health; 2023 Jan; 23(1):192. PubMed ID: 36709246
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
14. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
[TBL] [Abstract][Full Text] [Related]
15. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period.
Wouters OJ; Sandberg DM; Pillay A; Kanavos PG
Soc Sci Med; 2019 Jan; 220():362-370. PubMed ID: 30513486
[TBL] [Abstract][Full Text] [Related]
16. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
17. Medicines for cancers in children: The WHO model for selection of essential medicines.
Robertson J; Magrini N; Barr R; Forte G; Ondari C
Pediatr Blood Cancer; 2015 Oct; 62(10):1689-93. PubMed ID: 25929524
[TBL] [Abstract][Full Text] [Related]
18. Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward.
Jenei K; Aziz Z; Booth C; Cappello B; Ceppi F; de Vries EGE; Fojo A; Gyawali B; Ilbawi A; Lombe D; Sengar M; Sullivan R; Trapani D; Huttner BD; Moja L
Lancet Glob Health; 2022 Dec; 10(12):e1860-e1866. PubMed ID: 36183737
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children.
Petro E; Perumal-Pillay V; Mantel-Teeuwisse AK; van den Ham HA; Suleman F
J Pharm Policy Pract; 2024; 17(1):2290100. PubMed ID: 38205189
[TBL] [Abstract][Full Text] [Related]
20. The role of government agencies and other actors in influencing access to medicines in three East African countries.
Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
